IBDEI2LU ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41604,2)
 ;;=^5007455
 ;;^UTILITY(U,$J,358.3,41605,0)
 ;;=I69.293^^155^2061^16
 ;;^UTILITY(U,$J,358.3,41605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41605,1,3,0)
 ;;=3^Ataxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,41605,1,4,0)
 ;;=4^I69.293
 ;;^UTILITY(U,$J,358.3,41605,2)
 ;;=^5007487
 ;;^UTILITY(U,$J,358.3,41606,0)
 ;;=I69.093^^155^2061^14
 ;;^UTILITY(U,$J,358.3,41606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41606,1,3,0)
 ;;=3^Ataxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,41606,1,4,0)
 ;;=4^I69.093
 ;;^UTILITY(U,$J,358.3,41606,2)
 ;;=^5007423
 ;;^UTILITY(U,$J,358.3,41607,0)
 ;;=I69.893^^155^2061^15
 ;;^UTILITY(U,$J,358.3,41607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41607,1,3,0)
 ;;=3^Ataxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,41607,1,4,0)
 ;;=4^I69.893
 ;;^UTILITY(U,$J,358.3,41607,2)
 ;;=^5007549
 ;;^UTILITY(U,$J,358.3,41608,0)
 ;;=I69.391^^155^2061^17
 ;;^UTILITY(U,$J,358.3,41608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41608,1,3,0)
 ;;=3^Dysphagia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,41608,1,4,0)
 ;;=4^I69.391
 ;;^UTILITY(U,$J,358.3,41608,2)
 ;;=^5007516
 ;;^UTILITY(U,$J,358.3,41609,0)
 ;;=I69.191^^155^2061^18
 ;;^UTILITY(U,$J,358.3,41609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41609,1,3,0)
 ;;=3^Dysphagia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,41609,1,4,0)
 ;;=4^I69.191
 ;;^UTILITY(U,$J,358.3,41609,2)
 ;;=^5007453
 ;;^UTILITY(U,$J,358.3,41610,0)
 ;;=I69.291^^155^2061^20
 ;;^UTILITY(U,$J,358.3,41610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41610,1,3,0)
 ;;=3^Dysphagia following oth nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,41610,1,4,0)
 ;;=4^I69.291
 ;;^UTILITY(U,$J,358.3,41610,2)
 ;;=^5007485
 ;;^UTILITY(U,$J,358.3,41611,0)
 ;;=I69.091^^155^2061^19
 ;;^UTILITY(U,$J,358.3,41611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41611,1,3,0)
 ;;=3^Dysphagia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,41611,1,4,0)
 ;;=4^I69.091
 ;;^UTILITY(U,$J,358.3,41611,2)
 ;;=^5007421
 ;;^UTILITY(U,$J,358.3,41612,0)
 ;;=I69.891^^155^2061^21
 ;;^UTILITY(U,$J,358.3,41612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41612,1,3,0)
 ;;=3^Dysphagia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,41612,1,4,0)
 ;;=4^I69.891
 ;;^UTILITY(U,$J,358.3,41612,2)
 ;;=^5007547
 ;;^UTILITY(U,$J,358.3,41613,0)
 ;;=I69.321^^155^2061^22
 ;;^UTILITY(U,$J,358.3,41613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41613,1,3,0)
 ;;=3^Dysphasia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,41613,1,4,0)
 ;;=4^I69.321
 ;;^UTILITY(U,$J,358.3,41613,2)
 ;;=^5007492
 ;;^UTILITY(U,$J,358.3,41614,0)
 ;;=I69.121^^155^2061^23
 ;;^UTILITY(U,$J,358.3,41614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41614,1,3,0)
 ;;=3^Dysphasia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,41614,1,4,0)
 ;;=4^I69.121
 ;;^UTILITY(U,$J,358.3,41614,2)
 ;;=^5007428
 ;;^UTILITY(U,$J,358.3,41615,0)
 ;;=I69.021^^155^2061^24
 ;;^UTILITY(U,$J,358.3,41615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41615,1,3,0)
 ;;=3^Dysphasia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,41615,1,4,0)
 ;;=4^I69.021
 ;;^UTILITY(U,$J,358.3,41615,2)
 ;;=^5007396
 ;;^UTILITY(U,$J,358.3,41616,0)
 ;;=I69.821^^155^2061^26
